Swiss Vaccine Research Institute

The SVRI is driven by the common goal of international initiatives promoted at a political, corporate and academic level to reduce or eliminate suffering and death due to infectious diseases and cancer.

The SVRI will contribute to this goal through exploration, scientific discovery and translation of the discoveries into effective preventive vaccine strategies and therapeutic vaccine interventions for infectious diseases and for cancer.

The SVRI will encompass major facets of basic, clinical and translational research covering predominantly the three major infectious diseases: HIV/AIDS, malaria, tuberculosis, as well as the emerging influenza pandemic threat. The SVRI will also benefit from ongoing efforts in the area of cancer vaccine research.

 Dernière mise à jour le 26/09/2022 à 14:07